128 related articles for article (PubMed ID: 10496950)
1. Regulation of G protein activation and effector modulation by fusion proteins between the human 5-hydroxytryptamine(1A) receptor and the alpha subunit of G(i1): differences in receptor-constitutive activity imparted by single amino acid substitutions in G(i1)alpha.
Kellett E; Carr IC; Milligan G
Mol Pharmacol; 1999 Oct; 56(4):684-92. PubMed ID: 10496950
[TBL] [Abstract][Full Text] [Related]
2. Activation of constitutive 5-hydroxytryptamine(1B) receptor by a series of mutations in the BBXXB motif: positioning of the third intracellular loop distal junction and its G(o)alpha protein interactions.
Pauwels PJ; Gouble A; Wurch T
Biochem J; 1999 Oct; 343 Pt 2(Pt 2):435-42. PubMed ID: 10510311
[TBL] [Abstract][Full Text] [Related]
3. Dual coupling of cloned human 5-hydroxytryptamine1D alpha and 5-hydroxytryptamine1D beta receptors stably expressed in murine fibroblasts: inhibition of adenylate cyclase and elevation of intracellular calcium concentrations via pertussis toxin-sensitive G protein(s).
Zgombick JM; Borden LA; Cochran TL; Kucharewicz SA; Weinshank RL; Branchek TA
Mol Pharmacol; 1993 Sep; 44(3):575-82. PubMed ID: 8396718
[TBL] [Abstract][Full Text] [Related]
4. Analysis of agonist function at fusion proteins between the IP prostanoid receptor and cognate, unnatural and chimaeric G-proteins.
Fong CW; Milligan G
Biochem J; 1999 Sep; 342 ( Pt 2)(Pt 2):457-63. PubMed ID: 10455034
[TBL] [Abstract][Full Text] [Related]
5. Enhanced detection of receptor constitutive activity in the presence of regulators of G protein signaling: applications to the detection and analysis of inverse agonists and low-efficacy partial agonists.
Welsby PJ; Kellett E; Wilkinson G; Milligan G
Mol Pharmacol; 2002 May; 61(5):1211-21. PubMed ID: 11961140
[TBL] [Abstract][Full Text] [Related]
6. Mu-delta opioid receptor functional interaction: Insight using receptor-G protein fusions.
Snook LA; Milligan G; Kieffer BL; Massotte D
J Pharmacol Exp Ther; 2006 Aug; 318(2):683-90. PubMed ID: 16690720
[TBL] [Abstract][Full Text] [Related]
7. Reconstitution of the human 5-HT(1D) receptor-G-protein coupling: evidence for constitutive activity and multiple receptor conformations.
Brys R; Josson K; Castelli MP; Jurzak M; Lijnen P; Gommeren W; Leysen JE
Mol Pharmacol; 2000 Jun; 57(6):1132-41. PubMed ID: 10825383
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological characterization of the 5-hydroxytryptamine-1A receptor-mediated activation of high-affinity GTP hydrolysis in rat hippocampal membranes.
Odagaki Y; Fuxe K
J Pharmacol Exp Ther; 1995 Jul; 274(1):337-44. PubMed ID: 7616417
[TBL] [Abstract][Full Text] [Related]
9. Transfection of human 5-hydroxytryptamine1A receptors in NIH-3T3 fibroblasts: effects of increasing receptor density on the coupling of 5-hydroxytryptamine1A receptors to adenylyl cyclase.
Varrault A; Journot L; Audigier Y; Bockaert J
Mol Pharmacol; 1992 Jun; 41(6):999-1007. PubMed ID: 1614416
[TBL] [Abstract][Full Text] [Related]
10. Dopamine D2L receptor couples to G alpha i2 and G alpha i3 but not G alpha i1, leading to the inhibition of adenylate cyclase in transfected cell lines.
O'Hara CM; Tang L; Taussig R; Todd RD; O'Malley KL
J Pharmacol Exp Ther; 1996 Jul; 278(1):354-60. PubMed ID: 8764370
[TBL] [Abstract][Full Text] [Related]
11. 5-Hydroxytryptamine2A receptors expressed in rat renal mesangial cells inhibit cyclic AMP accumulation.
Garnovskaya MN; Nebigil CG; Arthur JM; Spurney RF; Raymond JR
Mol Pharmacol; 1995 Aug; 48(2):230-7. PubMed ID: 7651356
[TBL] [Abstract][Full Text] [Related]
12. A bioluminescent assay for agonist activity at potentially any G-protein-coupled receptor.
Stables J; Green A; Marshall F; Fraser N; Knight E; Sautel M; Milligan G; Lee M; Rees S
Anal Biochem; 1997 Oct; 252(1):115-26. PubMed ID: 9324949
[TBL] [Abstract][Full Text] [Related]
13. Partial rescue of functional interactions of a nonpalmitoylated mutant of the G-protein G alpha s by fusion to the beta-adrenergic receptor.
Ugur O; Onaran HO; Jones TL
Biochemistry; 2003 Mar; 42(9):2607-15. PubMed ID: 12614155
[TBL] [Abstract][Full Text] [Related]
14. Endogenous regulator of G protein signaling proteins suppress Galphao-dependent, mu-opioid agonist-mediated adenylyl cyclase supersensitization.
Clark MJ; Neubig RR; Traynor JR
J Pharmacol Exp Ther; 2004 Jul; 310(1):215-22. PubMed ID: 15014136
[TBL] [Abstract][Full Text] [Related]
15. Mutation of cysteine 214 in Gi1 alpha subunit abolishes its endogenous GTPase activity.
Wang Y; Tawa G; Smith D; Krishnamurthy G; Young KH
Biochem J; 2004 May; 379(Pt 3):673-9. PubMed ID: 14725508
[TBL] [Abstract][Full Text] [Related]
16. Delta opioid receptor down-regulation is independent of functional G protein yet is dependent on agonist efficacy.
Remmers AE; Clark MJ; Liu XY; Medzihradsky F
J Pharmacol Exp Ther; 1998 Nov; 287(2):625-32. PubMed ID: 9808689
[TBL] [Abstract][Full Text] [Related]
17. G(z) can mediate the acute actions of mu- and kappa-opioids but is not involved in opioid-induced adenylyl cyclase supersensitization.
Tso PH; Wong YH
J Pharmacol Exp Ther; 2000 Oct; 295(1):168-76. PubMed ID: 10991975
[TBL] [Abstract][Full Text] [Related]
18. Mutations of Cys-17 and Ala-271 in the human histamine H2 receptor determine the species selectivity of guanidine-type agonists and increase constitutive activity.
Preuss H; Ghorai P; Kraus A; Dove S; Buschauer A; Seifert R
J Pharmacol Exp Ther; 2007 Jun; 321(3):975-82. PubMed ID: 17347323
[TBL] [Abstract][Full Text] [Related]
19. Modulation of voltage-dependent calcium currents by serotonin in acutely isolated rat amygdala neurons.
Lin CH; Huang YC; Tsai JJ; Gean PW
Synapse; 2001 Sep; 41(4):351-9. PubMed ID: 11494406
[TBL] [Abstract][Full Text] [Related]
20. Supersensitivity to mu-opioid receptor-mediated inhibition of the adenylyl cyclase pathway involves pertussis toxin-resistant Galpha protein subunits.
Mostany R; Díaz A; Valdizán EM; Rodríguez-Muñoz M; Garzón J; Hurlé MA
Neuropharmacology; 2008 May; 54(6):989-97. PubMed ID: 18384820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]